@article{DashtiGrkovicAbdelmohsenetal.2014,
  author    = {Dashti, Yousef and Grkovic, Tanja and Abdelmohsen, Usama Ramadan and Hentschel, Ute and Quinn, Ronald J.},
  title     = {Production of Induced Secondary Metabolites by a Co-Culture of Sponge-Associated Actinomycetes, Actinokineospora sp EG49 and Nocardiopsis sp RV163},
  series = {MARINE DRUGS},
  volume    = {12},
  journal   = {MARINE DRUGS},
  number    = {5},
  issn      = {1660-3397},
  doi       = {10.3390/md12053046},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-116547},
  pages     = {3046-3059},
  year      = {2014},
  abstract  = {Two sponge-derived actinomycetes, Actinokineospora sp. EG49 and Nocardiopsis sp. RV163, were grown in co-culture and the presence of induced metabolites monitored by H-1 NMR. Ten known compounds, including angucycline, diketopiperazine and beta-carboline derivatives 1-10, were isolated from the EtOAc extracts of Actinokineospora sp. EG49 and Nocardiopsis sp. RV163. Co-cultivation of Actinokineospora sp. EG49 and Nocardiopsis sp. RV163 induced the biosynthesis of three natural products that were not detected in the single culture of either microorganism, namely N-(2-hydroxyphenyl)-acetamide (11), 1,6-dihydroxyphenazine (12) and 5a, 6,11a, 12-tetrahydro-5a, 11a-dimethyl[1,4]benzoxazino[3,2-b][1,4]benzoxazine (13a). When tested for biological activity against a range of bacteria and parasites, only the phenazine 12 was active against Bacillus sp. P25, Trypanosoma brucei and interestingly, against Actinokineospora sp. EG49. These findings highlight the co-cultivation approach as an effective strategy to access the bioactive secondary metabolites hidden in the genomes of marine actinomycetes.},
  language  = {en}
}
@article{ElHossaryAbdelHalimIbrahimetal.2020,
  author    = {El-Hossary, Ebaa M. and Abdel-Halim, Mohammad and Ibrahim, Eslam S. and Pimentel-Elardo, Sheila Marie and Nodwell, Justin R. and Handoussa, Heba and Abdelwahab, Miada F. and Holzgrabe, Ulrike and Abdelmohsen, Usama Ramadan},
  title     = {Natural Products Repertoire of the Red Sea},
  series = {Marine Drugs},
  volume    = {18},
  journal   = {Marine Drugs},
  number    = {9},
  issn      = {1660-3397},
  doi       = {10.3390/md18090457},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-213110},
  year      = {2020},
  abstract  = {Marine natural products have achieved great success as an important source of new lead compounds for drug discovery. The Red Sea provides enormous diversity on the biological scale in all domains of life including micro- and macro-organisms. In this review, which covers the literature to the end of 2019, we summarize the diversity of bioactive secondary metabolites derived from Red Sea micro- and macro-organisms, and discuss their biological potential whenever applicable. Moreover, the diversity of the Red Sea organisms is highlighted as well as their genomic potential. This review is a comprehensive study that compares the natural products recovered from the Red Sea in terms of ecological role and pharmacological activities.},
  language  = {en}
}
@article{AbdelmohsenYangHornetal.2014,
  author    = {Abdelmohsen, Usama Ramadan and Yang, Chen and Horn, Hannes and Hajjar, Dina and Ravasi, Timothy and Hentschel, Ute},
  title     = {Actinomycetes from Red Sea Sponges: Sources for Chemical and Phylogenetic Diversity},
  doi       = {10.3390/md12052771},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-112882},
  year      = {2014},
  abstract  = {The diversity of actinomycetes associated with marine sponges collected off Fsar Reef (Saudi Arabia) was investigated in the present study. Forty-seven actinomycetes were cultivated and phylogenetically identified based on 16S rRNA gene sequencing and were assigned to 10 different actinomycete genera. Eight putatively novel species belonging to genera Kocuria, Mycobacterium, Nocardia, and Rhodococcus were identified based on sequence similarity values below 98.2\% to other 16S rRNA gene sequences available in the NCBI database. PCR-based screening for biosynthetic genes including type I and type II polyketide synthases (PKS-I, PKS-II) as well as nonribosomal peptide synthetases (NRPS) showed that 20 actinomycete isolates encoded each at least one type of biosynthetic gene. The organic extracts of nine isolates displayed bioactivity against at least one of the test pathogens, which were Gram-positive and Gram-negative bacteria, fungi, human parasites, as well as in a West Nile Virus protease enzymatic assay. These results emphasize that marine sponges are a prolific resource for novel bioactive actinomycetes with potential for drug discovery.},
  subject      = {Meeresschw{\"a}mme},
  language  = {en}
}